earnings
RN
NASDAQ · RNXT
RenovoRx, Inc.
Healthcare · Biotechnology
$1.31
Up+$0.02 (+1.55%)
Updated Nov 5, 2026, 5:01 AM
SID Score
5.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 36.39M
- P/E ratio
- -3.41
- Dividend yield
- 0.00%
- 52-week range
- $0.77 – $2.59
- Volume
- 217.51K
- Avg. volume
- 506.07K
Price performance · RNXT
RNXT price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 4, 2026
RNXT closed at $1.31 after 21 trading sessions, down 4.38% for the selected period.
- Last close
- $1.31
- Period change
- -4.38%
- Period low
- $1.12
- Period high
- $1.49
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 4, 2026 | $1.33 | $1.37 | $1.27 | $1.31 | 217.51K |
| Nov 3, 2026 | $1.25 | $1.33 | $1.24 | $1.29 | 276.19K |
| Nov 2, 2026 | $1.31 | $1.335 | $1.23 | $1.26 | 304.28K |
| Oct 30, 2026 | $1.49 | $1.4969 | $1.30 | $1.33 | 376.39K |
| Oct 29, 2026 | $1.43 | $1.52 | $1.43 | $1.49 | 387.21K |
| Oct 28, 2026 | $1.42 | $1.46 | $1.35 | $1.425 | 173.14K |
| Oct 27, 2026 | $1.33 | $1.43 | $1.30 | $1.39 | 289.42K |
| Oct 26, 2026 | $1.30 | $1.34 | $1.27 | $1.31 | 182.31K |
| Oct 23, 2026 | $1.25 | $1.31 | $1.25 | $1.29 | 284.14K |
| Oct 22, 2026 | $1.23 | $1.28 | $1.22 | $1.27 | 226.27K |
| Oct 21, 2026 | $1.20 | $1.29 | $1.18 | $1.23 | 403.72K |
| Oct 20, 2026 | $1.16 | $1.24 | $1.16 | $1.20 | 264.59K |
| Oct 19, 2026 | $1.15 | $1.20 | $1.14 | $1.16 | 288.47K |
| Oct 16, 2026 | $1.21 | $1.22 | $1.14 | $1.14 | 277.13K |
| Oct 15, 2026 | $1.11 | $1.215 | $1.11 | $1.19 | 328.86K |
| Oct 14, 2026 | $1.13 | $1.155 | $1.09 | $1.12 | 628.41K |
| Oct 13, 2026 | $1.243 | $1.27 | $1.135 | $1.15 | 942.43K |
| Oct 12, 2026 | $1.26 | $1.32 | $1.25 | $1.25 | 256.06K |
| Oct 9, 2026 | $1.32 | $1.35 | $1.25 | $1.28 | 798.79K |
| Oct 8, 2026 | $1.33 | $1.37 | $1.31 | $1.33 | 438.65K |
| Oct 7, 2026 | $1.35 | $1.41 | $1.275 | $1.37 | 594.62K |
Latest RNXT news
The latest Smart Investors Daily articles mentioning RNXT.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

